Arterial pulsatility was measured using an optical interferometer. As opposed to laser Doppler flow meters, the prototype system we evaluated can detect pulsation profiles of major arteries with potentially useful information including pulse wave velocity, profile of pulse pressure, etc.
A system has been developed based on the measurement of skin surface vibration that can be used to detect the underlying vascular wall motion of superficial arteries and the chest wall. Data obtained from tissue phantoms suggested that the detected signals were related to intravascular pressure, an important clinical and physiological parameter. Unlike the conventional optical Doppler techniques that have been used to measure blood perfusion in skin layers and blood flow within superficial arteries, the present system was optimized to pick up skin vibrations. An optical interferometer with a 633-nm He:Ne laser was utilized to detect micrometer displacements of the skin surface. Motion velocity profiles of the skin surface near each superficial artery and auscultation points on a chest for the two heart valve sounds exhibited distinctive profiles. The theoretical and experimental results demonstrated that the system detected the velocity of skin movement, which is related to the time derivative of the pressure. The system also reduces the loading effect on the pulsation signals and heart sounds produced by the conventional piezoelectric vibration sensors. The system's sensitivity, which could be optimized further, was 366.2 m/s for the present research. Overall, optical cardiovascular vibrometry has the potential to become a simple noninvasive approach to cardiovascular screening.
A system has been developed based on the measurement of skin surface vibration that can be used to detect the underlying vascular wall motion of superficial arteries and the chest wall. Data obtained from tissue phantoms suggested that the detected signals were related to intravascular pressure, an important clinical and physiological parameter. Unlike the conventional optical Doppler techniques that have been used to measure blood perfusion in skin layers and blood flow within superficial arteries, the present system was optimized to pick up skin vibrations. An optical interferometer with a 633-nm He:Ne laser was utilized to detect micrometer displacements of the skin surface. Motion velocity profiles of the skin surface near each superficial artery and auscultation points on a chest for the two heart valve sounds exhibited distinctive profiles. The theoretical and experimental results demonstrated that the system detected the velocity of skin movement, which is related to the time derivative of the pressure. The system also reduces the loading effect on the pulsation signals and heart sounds produced by the conventional piezoelectric vibration sensors. The system's sensitivity, which could be optimized further, was 366.2 m/s for the present research. Overall, optical cardiovascular vibrometry has the potential to become a simple noninvasive approach to cardiovascular screening.
Autosomal dominant polycystic kidney disease (ADPKD) is a leading monogenetic cause of end-stage renal disease with limited therapeutic repertoire. A targeted drug delivery strategy that directs a small molecule to renal niches around cysts could increase the safety margins of agents that slow the progression of ADPKD but are poorly tolerated due to extrarenal toxicity. Herein, we determined whether previously characterized lysine-based and glutamic acid-based megalin-binding peptides can achieve renal-specific localization in the juvenile cystic kidney (JCK) mouse model of polycystic kidney disease and whether the distribution is altered compared with control mice. We performed in vivo optical and magnetic resonance imaging studies using peptides conjugated to the VivoTag 680 dye and demonstrated that megalin-interacting peptides distributed almost exclusively to the kidney cortex in both normal and JCK mice. Confocal analysis demonstrated that the peptide-dye conjugate distribution overlapped with megalin-positive renal proximal tubules. However, in the JCK mouse, the epithelium of renal cysts did not retain expression of the proximal tubule markers aquaporin 1 and megalin, and therefore these cysts did not retain peptide-dye conjugates. Furthermore, human kidney tumor tissues were evaluated by immunohistochemistry and revealed significant megalin expression in tissues from patients with renal cell carcinoma, raising the possibility that these tumors could be treated using this drug delivery strategy. Taken together, our data suggest that linking a small-molecule drug to these carrier peptides could represent a promising opportunity to develop a new platform for renal enrichment and targeting in the treatment of ADPKD and certain renal carcinomas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.